Premenstrual dysphoric disorder (PMDD) is not the main focus of this paper, but it is mentioned as a meaningful piece of a larger puzzle. The study examines whether depression during pregnancy and postpartum — called peripartum depression (PPD) — is truly the same condition as general depression or something distinct. One key finding relevant to people with PMDD: premenstrual syndrome was identified as the strongest biological predictor of postpartum depression. The authors note that some women appear to be especially sensitive to hormonal changes across their lives, and this sensitivity can show up as PMDD, depression during pregnancy or after birth, or mood difficulties during perimenopause.
The review found that peripartum depression looks different from general depression in important ways. People with peripartum depression tend to experience more anxiety, restlessness, trouble concentrating, and obsessive thoughts, but less sadness and fewer thoughts of suicide compared to general depression. Researchers identified five different subtypes of peripartum depression, many involving significant anxiety.
The authors argue that current diagnostic systems are too restrictive. Right now, the official definition only covers the first four to six weeks after birth, but evidence shows depression can start anytime during pregnancy through the first year postpartum. On average, full recovery takes nearly a year. The recurrence rate is high — about 43% for women with a prior history of depression.
For anyone with PMDD, this research reinforces what many already suspect: hormonal sensitivity is a thread that can connect mood challenges across different life stages. Having PMDD may increase vulnerability to depression during and after pregnancy, making it worth discussing with a healthcare provider when planning for or experiencing pregnancy.
Key findings
- PPD manifests with more anxiety, psychomotor symptoms, obsessive thoughts, impaired concentration, fatigue and loss of energy, but less sad mood and suicidal ideation compared to MDD
- PPD prevalence ranges from 12-17% in systematic reviews, with wider cross-cultural variation (15-65% during pregnancy, 3-38% postpartum) compared to MDD (5-7%)
- Premenstrual syndrome (PMS) was identified as the strongest biological predictor for postpartum depression, and differential gene expression in ovarian tissue was found in PPD compared to MDD
- The mean time for full remission of postpartum depression was 49 weeks, with 30% recovering at 6 months and 66% at 12 months
- Five distinct clinical subtypes of PPD were identified: severe anxious depression, moderate anxious depression, anxious anhedonia, pure anhedonia, and resolved depression
- Suicidal ideation prevalence in MDD is approximately 37.7% compared to approximately 11% pooled prevalence for peripartum suicidality
Methods, briefly
Narrative review following SANRA methodological guidelines. Literature search conducted September 2022 to March 2023 across Medline, PsycInfo, and WOS databases with no time restrictions. At least two authors screened literature on each of eight diagnostic topics. Inclusion criteria: English language papers on PPD diagnosis and related issues, with emphasis on systematic reviews/meta-analyses and empirical studies.
Limitations to keep in mind
- Not a systematic review; potential for selection bias in literature inclusion
- Reviewed studies were heterogeneous with varied methodologies, sample sizes, and assessment methods
- Direct comparisons between PPD and MDD in the same study were scarce; many inferences drawn from separate MDD and PPD studies
- PPD prevalence largely established via self-report questionnaires while MDD prevalence used diagnostic interviews, complicating direct comparison
- Age differences between PPD samples (reproductive age) and general MDD samples (broader age span) may confound comparisons
The latest PMDD research, in your pocket
The app’s research feed is updated daily with newly published, peer-reviewed PMDD work - summarized in plain language.